Posted On: 01/18/2015 12:09:21 AM
Post# of 30067
Re: Deputy_123 #15562
Quote:
It isn't realistic.
Was 3 of 4 of these events in the last two months realistic for a small "microcap" company? You just never know what's going to happen next.
Jan. 15, 2015 - Amarantus Announces Exclusive Option Agreement With Georgetown University to License Patent Rights for Blood Based Biomarkers for Alzheimer's Disease
Jan. 12, 2015 - Amarantus Announces Acquisition of Specialized Neuro-Diagnostics Company, DioGenix
Dec. 23, 2014 - Amarantus Receives Orphan Drug Designation for MANF From U.S. Food and Drug Administration for Treatment of Retinitis Pigmentosa
Nov. 17, 2014 - Amarantus Enters Into Exclusive Option Agreement to Acquire Engineered Skin Substitute for the Treatment of Severe Burns From Lonza
(0)
(0)
